🇺🇸 FDA
Patent

US 9850207

Substituted piperidines as soluble epdxide hydrolase inhibitors

granted A61KA61K31/4468

Quick answer

US patent 9850207 (Substituted piperidines as soluble epdxide hydrolase inhibitors) held by The Regents of the University of California expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/4468